Rongbin Ling is a notable inventor based in Xiamen, China, recognized for his contributions to pharmaceutical technologies. He holds a total of seven patents, showcasing his innovative approach to drug delivery systems.

Latest Patents

Among his latest inventions is an oral patch designed for treating mouth ulcers. This patch utilizes a combination of tetracaine and triamcinolone as active ingredients, featuring a bilayer structure that enhances efficacy compared to individual drugs. The drug layer consists of 3-20% by weight of amorphous tetracaine hydrochloride and 0.1-2.0% by weight of amorphous triamcinolone acetonide, along with other components to ensure optimal performance.

Another significant patent is the agomelatine oral transmucosal film, which delivers agomelatine through the buccal or sublingual mucosa. This film also features a bilayer structure, improving both bioavailability and palatability. The mucoadhesive layer contains 0.1%-40% by weight of amorphous agomelatine, ensuring effective drug delivery.

Career Highlights

Rongbin Ling is currently associated with Xiamen LP Pharmaceutical Co., Ltd., where he continues to innovate in the field of pharmaceuticals. His work focuses on developing advanced drug delivery systems that enhance therapeutic outcomes.

Collaborations

He collaborates with talented individuals such as Haijian Zhu and Avinash Singh, contributing to a dynamic research environment that fosters innovation.

Conclusion

Rongbin Ling's contributions to pharmaceutical technologies through his patents reflect his commitment to improving drug delivery systems. His innovative work continues to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com